Target intelligence / Profile preview

Small nucleolar RNA host gene 1 (SNHG1)

Target
SNHG1
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Small nucleolar RNA host gene
01

Overview

Small nucleolar RNA host gene 1 (SNHG1) is a long non-coding RNA (lncRNA) encoded by the SNHG1 gene in humans. It does not code for protein but regulates gene expression through multiple mechanisms, including acting as a molecular sponge for microRNAs, modulating DNA methylation, regulating transcription factors, and interacting with key tumor suppressor and oncogenic pathways. SNHG1 is frequently overexpressed in numerous cancers and is associated with promoting cell proliferation, invasion, and metastasis; it negatively regulates tumor suppressor genes such as p53 and contributes to poor prognosis when highly expressed. Alternative splicing of SNHG1 generates several small nucleolar RNAs. Although it is considered an emerging therapeutic target in cancer biology, there are currently no approved drugs specifically targeting SNHG1, and its main relevance is as an oncogenic driver and potential biomarker in solid tumors[1][2][3][4][7].

Other names
UHGNCRNA00057LINC00057lncRNA16U22 snoRNA host genenon-protein coding RNA 57long intergenic non-protein coding RNA 57U22HGU22 snoRNA host
02

Mechanism of action

No approved drugs, but experimental knockdown of SNHG1 (using siRNA or antisense oligonucleotides) inhibits cancer cell proliferation, invasion, and migration primarily via the modulation of specific miRNAs and gene pathways (e.g., as a competing endogenous RNA for miR-195, miR-326, miR-145; regulation of p53, Wnt/β-catenin pathway, Notch pathway)

03

Biological functions

Regulation of gene transcriptionRegulation of DNA methylationRegulation of cell proliferationActing as a molecular sponge for microRNAs (miRNA sponging)Repression of translationModulation of protein ubiquitinationRegulation of tumor suppressor genes (e.g., p53)Modulation of cell cycle and apoptosis
04

Disease associations

Cancer (multiple types, including hepatocellular carcinoma, colorectal cancer, ovarian cancer, prostate cancer, osteosarcoma, oral cavity cancer, breast cancer)Marker for tumor progression
05

Safety considerations

Potential safety concerns relate to the challenge of specifically targeting lncRNAs like SNHG1 systemically due to widespread expression and possible off-target effectsThe oncogenic effects of SNHG1 suggest that its inhibition could have antitumor effects, but specificity and delivery remain therapeutic challenges
06

Interacting drugs

None currently established as approved or clinical therapeutics directly targeting SNHG1
07

Biomarkers

SNHG1 expression may serve as a prognostic biomarker for tumor progression and poor prognosis in several cancer types

Beyond the preview

Go deeper on Small nucleolar RNA host gene 1 (SNHG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA host gene 1 (SNHG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call